Syngene International Limited Share Price and Company Fundamentals
Last traded: Today at 10:00 AM
Syngene International Limited, a contract research and manufacturing company, provides drug discovery and development services in India, the United States of America, Europe, and internationally. The company provides discovery chemistry services, such as synthetic and medicinal chemistry, library and peptide synthesis, biomolecular science, organic electronic materials, and computational and analytical chemistry; discovery biology services in the areas of recombinant DNA engineering, cell line development, hybridoma technology, sequencing, protein sciences, screening and assay biology, DMPK, in vivo pharmacology, toxicology, and biologicals; and chemical, formulation, analytical, and clinical development services. It provides lead generation, preclinical development, API, and drug product development services; and clinical trial management, pharmacokinetic analysis/bioanalytical studies, biometrics and clinical data management, central lab, regulatory, medical monitoring, pharmacovigilance, and medical writing services. In addition, the company offers chemistry, biology, safety assessment, computational, and data sciences for traditional small molecule therapeutics; biologics; and specialty modalities, such as peptides, oligonucleotides, antibody-drug conjugates, and targeted degradation/stabilization. It serves pharmaceutical, biotechnology, animal health, nutrition, consumer goods, agrochemical, performance and specialty materials, and other companies. The company has collaborations with Bristol-Myers Squibb, Baxter Inc., and Amgen Inc. The company was incorporated in 1993 and is headquartered in Bengaluru, India. Syngene International Limited is a subsidiary of Biocon Limited.
Key Metrics
PE ratio
45.84
PB ratio
3.39
Dividend yield
0.31%
Beta
-0.26
Market cap
₹160.65B
Enterprise value
₹141.14B
Company profile
| Industry / Sector | Diagnostics & Research / Healthcare |
|---|---|
| Full time employees | 6533 |
| Website | https://www.syngeneintl.com |
| Mailing address | Biocon SEZ, Biocon Park Plot No. 2 & 3 Bommasandra Industrial Area, IV Phase Jigani Link Road Bengaluru 560099 India |
| Phone / Fax | 91 80 6891 8000 / 91 80 6891 8808 |
Dividends
Dividend yield
0.31%
Dividend amount
₹1.25
Payout ratio
14.30%
5Y Avg. yield
-%
Syngene International Limited paid ₹1.25 dividend and the ex-dividend date was 27 Jun 2025.The dividend payout ratio is 14.30%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.SYNGENE dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
Company Executives
As of Mar 2026, following are the company executives and directors listed on Syngene International Limited.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Mr. Peter James Jonathan Bains | CEO, MD & Director | 68 | |
| Mr. Deepak Jain | Chief Financial Officer | ||
| Mr. Gaurav Kushwaha | Chief Technology Officer | ||
| Dr. Jayashree Aiyar Ph.D. | Chief Scientific Officer | ||
| Mr. G. Krishnan | Head of Investor Relations | ||
| Mr. Chethan Yogesh | Company Secretary & Compliance Officer | ||
| Mr. Surender Kumar Sharma | General Counsel | 50 | |
| Mr. Sandeep Nair | Head of Corporate Communications | ||
| Mr. Ajay Tandon | Head of Strategy & Corporate Development | ||
| Mr. Andrew Webster | Chief Human Resources Officer |
Profitability and management effectiveness
Profit margin
9.46%
Operating margin
12.94%
Return on assets
-
Return on equity
-
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Syngene International Limited is 160.65B and its enterprise value is 141.14B. The enterprise value to revenue ratio of SYNGENE is 3.79. The enterprise value to EBITDA ratio of SYNGENE is 15.16.
Syngene International Limited (NSE:SYNGENE) Frequently Asked Questions
1. What is Syngene International Limited's Stock Symbol?
Syngene International Limited trades on NSE under the ticker symbol "SYNGENE".
2. What is Syngene International Limited's stock price today?
One share of SYNGENE stock can currently be purchased for approximately ₹399.7.
3. How can I contact Syngene International Limited?
Syngene International Limited's mailing address is Biocon SEZ, Biocon Park Plot No. 2 & 3 Bommasandra Industrial Area, IV Phase Jigani Link Road Bengaluru 560099 India. The company can be reached via phone at 91 80 6891 8000.
4. What is Syngene International Limited's official website?
The official website of Syngene International Limited is https://www.syngeneintl.com.